Jenny Chung, Shari R Lipner
The menopause care market is experiencing unprecedented growth, with unregulated dietary supplements representing one of the largest segments despite knowledge gaps [1]. Menopause-related dermatologic changes can substantially impact quality of life [2], making menopausal women primary targets for direct-to-consumer dietary supplements and health claims on social media platforms. This raises an ethical question of how to provide high-quality dermatologic care to menopausal women which can be examined through ethical principles of beneficence, non-maleficence, justice, and respect for autonomy. Dermatologists have an ethical obligation to offer evidence-based recommendations and engage in shared decision-making that aligns patient goals with realistic expectations about dermatologic changes in menopause.